Ironsides Asset Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,336
| Closed | -$207K | – | 84 |
|
|
2023
Q3 | $207K | Sell |
2,336
-400
| -15% | -$35.4K | 0.09% | 63 |
|
|
2023
Q2 | $237K | Sell |
2,736
-200
| -7% | -$17.3K | 0.1% | 69 |
|
|
2023
Q1 | $285K | Hold |
2,936
| – | – | 0.13% | 61 |
|
|
2022
Q4 | $304K | Hold |
2,936
| – | – | 0.14% | 58 |
|
|
2022
Q3 | $249K | Buy |
2,936
+30
| +1% | +$2.54K | 0.11% | 66 |
|
|
2022
Q2 | $241K | Sell |
2,906
-30
| -1% | -$2.49K | 0.09% | 71 |
|
|
2022
Q1 | $226K | Hold |
2,936
| – | – | 0.07% | 85 |
|
|
2021
Q4 | $259K | Sell |
2,936
-1,390
| -32% | -$123K | 0.07% | 77 |
|
|
2021
Q3 | $334K | Sell |
4,326
-2,000
| -32% | -$154K | 0.11% | 69 |
|
|
2021
Q2 | $528K | Sell |
6,326
-1,040
| -14% | -$86.8K | 0.16% | 46 |
|
|
2021
Q1 | $556K | Buy |
7,366
+20
| +0.3% | +$1.51K | 0.17% | 43 |
|
|
2020
Q4 | $644K | Buy |
7,346
+160
| +2% | +$14K | 0.2% | 45 |
|
|
2020
Q3 | $547K | Sell |
7,186
-2,969
| -29% | -$226K | 0.17% | 54 |
|
|
2020
Q2 | $1.25M | Hold |
10,155
| – | – | 0.41% | 25 |
|
|
2020
Q1 | $858K | Buy |
10,155
+6,175
| +155% | +$522K | 0.52% | 23 |
|
|
2019
Q4 | $337K | Sell |
3,980
-10,955
| -73% | -$928K | 0.11% | 76 |
|
|
2019
Q3 | $1.01M | Hold |
14,935
| – | – | 0.34% | 39 |
|
|
2019
Q2 | $1.28M | Buy |
14,935
+3,915
| +36% | +$335K | 0.43% | 31 |
|
|
2019
Q1 | $979K | Hold |
11,020
| – | – | 0.32% | 34 |
|
|
2018
Q4 | $938K | Buy |
11,020
+7,525
| +215% | +$641K | 0.34% | 33 |
|
|
2018
Q3 | $339K | Hold |
3,495
| – | – | 0.1% | 86 |
|
|
2018
Q2 | $329K | Hold |
3,495
| – | – | 0.11% | 88 |
|
|
2018
Q1 | $283K | Sell |
3,495
-200
| -5% | -$16.2K | 0.11% | 81 |
|
|
2017
Q4 | $329K | Hold |
3,695
| – | – | 0.13% | 76 |
|
|
2017
Q3 | $344K | Buy |
+3,695
| New | +$344K | 0.14% | 75 |
|